Stocksigma LogoStocksigma Logo

Essix Biosciences Increases Stake in Ind-Swift Laboratories via Warrant Conversion

Essix Biosciences Limited, part of the promoter group of Ind-Swift Laboratories Limited, acquired 14,00,000 equity shares (1.58% voting capital) on 8th

Essix Biosciences Increases Stake in Ind-Swift Laboratories via Warrant Conversion

Ind-Swift Laboratories Ltd 路 Others (Uncategorized) 路 12 Oct 2026, 11:05 pm

Essix Biosciences Increases Stake in Ind-Swift Laboratories via Warrant Conversion Essix Biosciences Limited, part of the promoter group of Ind-Swift Laboratories Limited, acquired 14,00,000 equity shares (1.58% voting capital) on 8th Oct'26 through the conversion of preferential convertible warrants. Post-allotment, Essix Biosciences' direct shareholding increased from 37.81% (3,28,82,521 shares) to 38.80% (3,42,82,521 shares), while combined promoter and PAC voting rights rose to 43.84% (4,43,34,278 shares). Ind-Swift's total paid-up voting equity expanded to Rs. 88.36 cr (8,83,61,558 shares of Rs. 10 each), with total diluted capital standing at Rs. 93.96 cr.

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements